These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19961932)

  • 1. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz.
    Soyinka JO; Onyeji CO
    Eur J Pharm Sci; 2010 Feb; 39(4):213-8. PubMed ID: 19961932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.
    Soyinka JO; Onyeji CO; Omoruyi SI; Owolabi AR; Sarma PV; Cook JM
    Br J Clin Pharmacol; 2010 Mar; 69(3):262-70. PubMed ID: 20233197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
    van Luin M; Van der Ende ME; Richter C; Visser M; Faraj D; Van der Ven A; Gelinck L; Kroon F; Wit FW; Van Schaik RH; Kuks PF; Burger DM
    AIDS; 2010 May; 24(8):1223-6. PubMed ID: 20299957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of African potato (Hypoxis hemerocallidea) on the pharmacokinetics of efavirenz.
    Mogatle S; Skinner M; Mills E; Kanfer I
    S Afr Med J; 2008 Dec; 98(12):945-9. PubMed ID: 19374071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride.
    Jamaludin A; Mohamad M; Navaratnam V; Yeoh PY; Wernsdorfer WH
    Trop Med Parasitol; 1990 Sep; 41(3):268-72. PubMed ID: 2255843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects.
    Ji P; Damle B; Xie J; Unger SE; Grasela DM; Kaul S
    J Clin Pharmacol; 2008 Aug; 48(8):948-56. PubMed ID: 18519918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers.
    Funakoshi R; Tomoda Y; Kudo T; Furihata K; Kusuhara H; Ito K
    Br J Clin Pharmacol; 2019 Jul; 85(7):1454-1463. PubMed ID: 30845361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
    Aarnoutse RE; Grintjes KJ; Telgt DS; Stek M; Hugen PW; Reiss P; Koopmans PP; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2002 Jan; 71(1):57-67. PubMed ID: 11823758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
    Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A
    Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a pharmacokinetic interaction between atovaquone and proguanil.
    Gillotin C; Mamet JP; Veronese L
    Eur J Clin Pharmacol; 1999 Jun; 55(4):311-5. PubMed ID: 10424325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir.
    Iwamoto M; Wenning LA; Petry AS; Laethem M; De Smet M; Kost JT; Breidinger SA; Mangin EC; Azrolan N; Greenberg HE; Haazen W; Stone JA; Gottesdiener KM; Wagner JA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4338-43. PubMed ID: 18838589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of the lopinavir/ritonavir tablet 500/125 mg twice daily coadministered with efavirenz in healthy adult participants.
    Ng J; Chiu YL; Awni W; Bernstein B; Causemaker SJ; Klein CE
    J Clin Pharmacol; 2012 Aug; 52(8):1248-54. PubMed ID: 21719718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Siringhaus T; Herpok L; Bethel-Brown C; Manthos H; Brejda J; Gartner M
    Biopharm Drug Dispos; 2016 Dec; 37(9):542-549. PubMed ID: 27704562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.
    Soyinka JO; Onyeji CO; Omoruyi SI; Owolabi AR; Sarma PV; Cook JM
    J Pharm Pharmacol; 2009 Apr; 61(4):439-43. PubMed ID: 19298689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.
    Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB
    Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
    Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
    Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.